These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 25628060)
1. Translation from clinical trials to routine practice: how to demonstrate community benefit. Roder D; Buckley E Asia Pac J Clin Oncol; 2015 Mar; 11(1):1-3. PubMed ID: 25628060 [No Abstract] [Full Text] [Related]
2. Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice. Lok SW; Wong HL; Kosmider S; Field K; Tie J; Desai J; Bae S; Tacey M; Skinner I; Jones I; Gibbs P Asia Pac J Clin Oncol; 2014 Dec; 10(4):361-7. PubMed ID: 25131961 [TBL] [Abstract][Full Text] [Related]
3. Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy. Huang SC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Lin CC; Jiang JK; Chang SC Ann Surg Oncol; 2015 Jul; 22(7):2262-8. PubMed ID: 25586242 [TBL] [Abstract][Full Text] [Related]
4. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial. Stintzing S; Modest DP; Rossius L; Lerch MM; von Weikersthal LF; Decker T; Kiani A; Vehling-Kaiser U; Al-Batran SE; Heintges T; Lerchenmüller C; Kahl C; Seipelt G; Kullmann F; Stauch M; Scheithauer W; Held S; Giessen-Jung C; Moehler M; Jagenburg A; Kirchner T; Jung A; Heinemann V; Lancet Oncol; 2016 Oct; 17(10):1426-1434. PubMed ID: 27575024 [TBL] [Abstract][Full Text] [Related]
5. Tailoring the colorectal cancer disease assessment to the treatment strategy. Deming DA Gut; 2018 Jun; 67(6):996-997. PubMed ID: 29269439 [No Abstract] [Full Text] [Related]
6. Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer. Cubillo A; Rodriguez-Pascual J; López-Ríos F; Plaza C; García E; Álvarez R; de Vicente E; Quijano Y; Hernando O; Rubio C; Perea S; Sanchez G; Hidalgo M Am J Clin Oncol; 2016 Jun; 39(3):236-42. PubMed ID: 24517959 [TBL] [Abstract][Full Text] [Related]
7. Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice? Bria E; Di Maio M; Cuppone F; Nisticò C; Cognetti F; Giannarelli D J Clin Oncol; 2007 Feb; 25(5):605-6; author reply 606-7. PubMed ID: 17290074 [No Abstract] [Full Text] [Related]
8. [Chemotherapy of inoperable colorectal cancer]. Herrmann R Wien Med Wochenschr; 1988 Jul; 138(13):310-3. PubMed ID: 3055690 [TBL] [Abstract][Full Text] [Related]
9. [Combined therapy of rectal tumors: the chemotherapy]. Di Bartolomeo M; Bajetta E; Beretta E; Buzzoni R Tumori; 2001; 87(1 Suppl 1):S31-2. PubMed ID: 11300018 [No Abstract] [Full Text] [Related]
10. Costs of chemotherapy in the treatment of colorectal cancer. Jansman FG; Postma MJ Eur J Health Econ; 2006 Jun; 7(2):145-6. PubMed ID: 16699776 [No Abstract] [Full Text] [Related]